Lilly in Canada
Lilly Canada is the Canadian affiliate of Eli Lilly and Company, one of the world’s largest research-based pharmaceutical companies. Our affiliate was founded in 1938 as a result of a collaboration between Eli Lilly and Company and Banting and Best, which produced the world’s first commercially available insulin.
Our work has broadened, and we now focus on diabetes, cancer, immunology, pain and neurodegeneration. Our products save and improve lives. Pharmaceuticals also save overall health care costs by improving health outcomes, reducing the need for surgeries, hospitalization, and extended care, and allowing people to return to work sooner. We unite caring with discovery to create medicines that make life better for people around the world.
Lilly employees work to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism. We employ approximately 325 people across the country.
Lilly Canada built our first facility in 1946 at 3650 Danforth Road. Today our Canadian headquarters is still located in Toronto, Ontario. Our downtown office keeps us close to hospitals, universities, and research facilities—to our collaborators of the past and the future.
2020 Lilly Canada
80+ years in Canada
Almost $26.4 million CAD of R&D, plus more than $100 million USD as part of our agreement with AbCellera
Managed research at 418 sites across Canada
Distributed more than $27.6 million in community support
Driven By Innovation
To solve some of the toughest challenges in medicine we need the most innovative ideas. That is why we are committed to creating and sustaining an open, inclusive and diverse environment, where everyone feels valued, respected and heard. Through the sharing of diverse perspectives, experiences and skills, we can inspire each other to think differently, generate ideas and deliver innovative health care solutions.
The people who work at Lilly have dedicated our careers to making life better for people by inventing and commercializing innovative medicines. From the first stages of discovery, through the years of clinical testing, to the detailed and difficult work of securing approval to call a new molecule a medicine, our team is focused on delivering safe, effective treatments to the people who need them.
Andrew MerrickDirector of Patient Access and 30+ year employee of Lilly Canada